Kevin Bigaut
Overview
Explore the profile of Kevin Bigaut including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
498
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berthet E, Guillonnet A, Houillier C, Ursu R, Soussain C, Touat M, et al.
Ann Neurol
. 2024 Nov;
97(3):435-448.
PMID: 39605186
Objective: Intravascular lymphoma is a rare subtype of B-cell lymphoma characterized by a clonal proliferation restricted to the lumen of small vessels. Over 50% of patients exhibit central nervous system...
2.
Gavoille A, Rollot F, Casey R, Kerbrat A, Le Page E, Bigaut K, et al.
JAMA Neurol
. 2024 Jul;
81(8):814-823.
PMID: 38949816
Importance: Understanding the association between clinically defined relapses and radiological activity in multiple sclerosis (MS) is essential for patient treatment and therapeutic development. Objective: To investigate clinical events identified as...
3.
Jouvenot G, Courbon G, Lefort M, Rollot F, Casey R, Le Page E, et al.
JAMA Neurol
. 2024 Mar;
81(5):490-498.
PMID: 38526462
Importance: A recent randomized clinical trial concluded that discontinuing medium-efficacy therapy might be a reasonable option for older patients with nonactive multiple sclerosis (MS), but there is a lack of...
4.
De Seze J, Clerc C, Bereau M, Bourre B, Zephir H, Collongues N, et al.
Mult Scler J Exp Transl Clin
. 2024 Mar;
10(1):20552173241233952.
PMID: 38435499
Objective: To assess the efficacy of dalfampridine in patients with neuromyelitis optica spectrum disorder. Methods: We included 15 consecutive patients, who were started on a treatment of dalfampridine 10 mg...
5.
Collongues N, Durand-Dubief F, Lebrun-Frenay C, Audoin B, Ayrignac X, Bensa C, et al.
Mult Scler
. 2024 Feb;
30(7):899-924.
PMID: 38357870
Background: Epidemiological data reveal that 45% of persons with multiple sclerosis (PwMS) in France are more than 50 years. This population more than 50 is more susceptible to cancer, and...
6.
Moreau A, Kolitsi I, Kremer L, Fleury M, Lanotte L, Sellal F, et al.
Mult Scler Relat Disord
. 2023 Aug;
79:104942.
PMID: 37633034
Background: Pediatric forms of multiple sclerosis are more active than those in adults. Yet, the effectiveness of different therapeutic approaches is not well studied in this population. Our objective was...
7.
Clinical features and maternal and fetal outcomes in women with Guillain-Barré syndrome in pregnancy
Krief N, Gabriel R, Cauquil C, Adams D, Fargeot G, Maisonobe T, et al.
J Neurol
. 2023 Jun;
270(9):4498-4506.
PMID: 37294323
Background: Guillain-Barre syndrome (GBS) is an acute inflammatory polyradiculoneuropathy rarely observed during pregnancy. Methods: In this retrospective study, we analyzed the characteristics of pregnant women with GBS (pGBS) diagnosed in...
8.
Pelle J, Briant A, Branger P, Derache N, Arnaud C, Lebrun-Frenay C, et al.
Neurol Ther
. 2023 Feb;
12(2):529-542.
PMID: 36763307
Introduction: Natalizumab, a therapy for relapsing-remitting multiple sclerosis (RRMS), is associated with a risk of progressive multifocal leukoencephalopathy (PML). Over the last several years, practitioners have used off-label extended interval...
9.
Levraut M, Laurent-Chabalier S, Ayrignac X, Bigaut K, Rival M, Squalli S, et al.
Neurol Neuroimmunol Neuroinflamm
. 2022 Nov;
10(1).
PMID: 36376096
Background And Objectives: Kappa free light chains (KFLC) seem to efficiently diagnose MS. However, extensive cohort studies are lacking to establish consensus cut-offs, notably to rule out non-MS autoimmune CNS...
10.
Vukusic S, Marignier R, Ciron J, Bourre B, Cohen M, Deschamps R, et al.
Mult Scler
. 2022 Nov;
29(1):37-51.
PMID: 36345839
Background: In 2020, the French Multiple Sclerosis (MS) Society (SFSEP) decided to develop a national evidence-based consensus on pregnancy in MS. As neuromyelitis optica spectrum disorders (NMOSD) shares a series...